<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
70383-130-01
</NDCCode>
<PackageDescription>
26 mL in 1 VIAL, SINGLE-DOSE (70383-130-01)
</PackageDescription>
<NDC11Code>
70383-0130-01
</NDC11Code>
<ProductNDC>
70383-130
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ustekinumab
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION, CONCENTRATE
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20250303
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
BioConnection B.V.
</LabelerName>
<SubstanceName>
USTEKINUMAB
</SubstanceName>
<StrengthNumber>
5
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-07-19
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
03-MAR-25
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>